BOSTON, Oct. 16 /PRNewswire-FirstCall/ --Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Companyhas received multiple purchase orders for its MammoView(TM) line of surgical endoscopy instruments from Wheaton Franciscan Healthcare. Wheaton Franciscan Healthcare is one of the largest integrated, non-profit healthcare systems in Wisconsin.
Wheaton Franciscan Healthcare provides nearly one-fourth of the total health care delivered in Milwaukee, Waukesha, Washington, Racine, and Ozaukee counties. With nearly 12,000 associates in Southeast Wisconsin, Wheaton Franciscan is the state's second largest private employer. Wheaton’s growing financial strength gives them the means to reinvest in facilities, technology and clinical programming, ensuring that they will continue to provide exceptional care with the latest technology. Wheaton has six major acute centers across the state, hospice services, full medical laboratory, outpatient clinics, and programs designed to enhance their patents health and wellness.
"We are excited to be supplying our MammoView surgical endoscopy line of instruments to one of Wisconsin’s most technologically advanced health care systems. Our product line is key in assisting doctors in diagnosing cancer at an early stage where patient treatment can commence immediately," stated Bob Segersten, President of Solos Endoscopy, Inc.
Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its MammoView™ line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.
For more information on Wheaton Franciscan Healthcare, please visit www.mywheaton.org.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
Subscribe to our Free Newsletters!
Statins are a group of drugs which help to lower the blood cholesterol levels.
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids ...